Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes
- PMID: 25448601
- PMCID: PMC4315763
- DOI: 10.1016/j.neurobiolaging.2014.09.027
Alzheimer's disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes
Abstract
Alzheimer's disease (AD) is characterized by deficits in cerebral metabolic rates of glucose in the posterior cingulate (PC) and precuneus in AD subjects, and in APOEε4 carriers, decades before the onset of measureable cognitive deficits. However, the cellular and molecular basis of this phenotype remains to be clarified. Given the roles of astrocytes in energy storage and brain immunity, we sought to characterize the transcriptome of AD PC astrocytes. Cells were laser capture microdissected from AD (n = 10) and healthy elderly control (n = 10) subjects for RNA sequencing. We generated >5.22 billion reads and compared sequencing data between controls and AD patients. We identified differentially expressed mitochondria-related genes including TRMT61B, FASTKD2, and NDUFA4L2, and using pathway and weighted gene coexpression analyses, we identified differentially expressed immune response genes. A number of these genes, including CLU, C3, and CD74, have been implicated in beta amyloid generation or clearance. These data provide key insights into astrocyte-specific contributions to AD, and we present this data set as a publicly available resource.
Keywords: Alzheimer's disease; Astrocytes; Immune response; Mitochondria; Posterior cingulate; RNA sequencing.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Circular RNA expression and regulatory network prediction in posterior cingulate astrocytes in elderly subjects.BMC Genomics. 2018 May 9;19(1):340. doi: 10.1186/s12864-018-4670-5. BMC Genomics. 2018. PMID: 29739336 Free PMC article.
-
Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.Neurobiol Aging. 2015 Feb;36(2):1221.e15-28. doi: 10.1016/j.neurobiolaging.2014.09.003. Epub 2014 Sep 6. Neurobiol Aging. 2015. PMID: 25281018
-
PSEN1 Mutant iPSC-Derived Model Reveals Severe Astrocyte Pathology in Alzheimer's Disease.Stem Cell Reports. 2017 Dec 12;9(6):1885-1897. doi: 10.1016/j.stemcr.2017.10.016. Epub 2017 Nov 16. Stem Cell Reports. 2017. PMID: 29153989 Free PMC article.
-
The contribution of astrocytes to Alzheimer's disease.Biochem Soc Trans. 2014 Oct;42(5):1316-20. doi: 10.1042/BST20140171. Biochem Soc Trans. 2014. PMID: 25233409 Review.
-
When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.Ageing Res Rev. 2014 Nov;18:29-40. doi: 10.1016/j.arr.2014.07.004. Epub 2014 Jul 28. Ageing Res Rev. 2014. PMID: 25078115 Review.
Cited by
-
Mitochondrial 16S rRNA Is Methylated by tRNA Methyltransferase TRMT61B in All Vertebrates.PLoS Biol. 2016 Sep 15;14(9):e1002557. doi: 10.1371/journal.pbio.1002557. eCollection 2016 Sep. PLoS Biol. 2016. PMID: 27631568 Free PMC article.
-
Deterioration of neuroimmune homeostasis in Alzheimer's Disease patients who survive a COVID-19 infection.J Neuroinflammation. 2024 Aug 17;21(1):202. doi: 10.1186/s12974-024-03196-3. J Neuroinflammation. 2024. PMID: 39154174 Free PMC article.
-
Therapeutic Potential of Astrocyte Transplantation.Cell Transplant. 2022 Jan-Dec;31:9636897221105499. doi: 10.1177/09636897221105499. Cell Transplant. 2022. PMID: 35770772 Free PMC article. Review.
-
Deciphering the Astrocyte Reaction in Alzheimer's Disease.Front Aging Neurosci. 2018 Apr 25;10:114. doi: 10.3389/fnagi.2018.00114. eCollection 2018. Front Aging Neurosci. 2018. PMID: 29922147 Free PMC article. Review.
-
Transcriptomic Analyses of Neurotoxic Astrocytes Derived from Adult Triple Transgenic Alzheimer's Disease Mice.J Mol Neurosci. 2023 Aug;73(7-8):487-515. doi: 10.1007/s12031-023-02105-2. Epub 2023 Jun 15. J Mol Neurosci. 2023. PMID: 37318736
References
-
- Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 1997;42(1):85–94. - PubMed
-
- Reiman EM, Caselli RJ, Chen K, Alexander GE, Bandy D, Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci U S A. 2001;98(6):3334–3339. - PMC - PubMed
-
- Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med. 1996;334(12):752–758. - PubMed
-
- Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Am J Psychiatry. 2002;159(5):738–745. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous